Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12

International Journal of Cancer

Volumn 82, Issue 5, 1999, Pages 714-720

  Joki, Tatsuhiro ^a   Kikuchi, Tetsuro ^a   Akasaki, Yasuharu ^a   Saitoh, Saburo ^a   Abe, Toshiaki ^a   Ohno, Tsuneya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT INTERLEUKIN 12; CANCER ANTIBODY; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR IMMUNITY; ACTIVE IMMUNIZATION; ANIMAL; BRAIN TUMOR; CANCER TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; FEMALE; GENETICS; IMMUNOLOGY; MORTALITY; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, CD80; BRAIN NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; GLIOMA; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; MICE; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033609698     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990827)82:5<714::aid-ijc15>3.3.co;2-h     Document Type: Article

References (15)

1. AOKI, T., TASHIRO, K., MIYATAKE, S., KINASHI, T., NAKANO, T., ODA, Y., KIKUCHI, H. and HONJO, T., Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. nat. Acad. Sci. (Wash.), 89, 3850-3854 (1992).
2. BASKAR, S., OSTRAND, R.S., NABAVI, N., NADLER, L.M., FREEMAN, G.J. and GLIMCHER, L.H., Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. nat. Acad. Sci. (Wash.), 90, 5687-5690 (1993).
3. BIANCHI, R., GROHMANN, U., BELLADONNA, M.L., SILLA, S., FALLARINO, F., AYROLDI, E., FIORETTI, M.C. and PUCCETTI, P., IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J. Immunol., 157, 1589-1597 (1996).
4. BRUNDA, M.J., LUISTRO, L., RUMENNIK, L., WRIGHT, R.B., DVOROZNIAK, M., AGLIONE, A., WIGGINTON, J.M., WILTROUT, R.H., HENDRZAK, J.A. and PALLERONI, A.V., Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother. Pharmacol., 38 (Suppl.), S12-S21 (1996).
5. CAVALLO, F., MARTIN, F.A., BELLONE, M., HELTAI, S., GATTI, E., TORNAGHI, P., FRESCHI, M., FORNI, G., DELLABONA, P. and CASORATI, G., Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Europ. J. Immunol., 25, 1154-1162 (1995).
6. CAYEUX, S., BECK, C., DORKEN, B. and BLANKENSTEIN, T., Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant. Hum. Gene Ther., 7, 525-529 (1996).
7. CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTRÖM, I. and HELLSTRÖM, K.E., Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. exp. Med., 179, 523-532 (1994).
8. CSERR, H.F. and KNOPF, P.M., Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today, 13, 507-512 (1992).
9. FREEMAN, G.J., DISTECHE, C.M., GRIBBEN, J.G., ADLER, D.A., FREEDMAN, A.S., DOUGERY, J. and NADLER, L.M., The gene for B7, a costimulatory signal for T-cell activation, maps to chromosomal region 3q13.3-3q21. Blood, 79, 489-494 (1992).
10. +-mediated rejection of established tumors. Hum. Gene Ther., 8, 477-488 (1997).
11. NISHIO, M., SPIELMAN, J., LEE, R.K., NELSON, D.L. and PODACK, E.R., CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J. Immunol., 157, 4347-4353 (1996).
12. PUTZER, B.M., HITT, M., MULLER, W.J., EMTAGE, P., GAULDIE, J. and GRAHAM, F.L., Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc. nat. Acad. Sci. (Wash.), 94, 10889-10894 (1997).
13. RAES, G., VAN GINDERACHTER, J., LIU, Y.Q., BRYS, L., THIELEMANS, K., DE BAETSELIER, P. and GELDHOF, A., Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model. Cancer Immunol. Immunother., 45, 257-265 (1998).
14. RAO, J.B., CHAMBERLAIN, R.S., BRONTE, V., CARROLL, M.W., IRVINE, K.R., Moss, B., ROSENBERG, S.A. and RESTIFO, N.P., IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol., 156, 3357-3365 (1996).
15. SAKAMOTO, K., HOSHINO, H., KIUCHI, Y., NAKANO, G. and NAGAMACHI, Y., Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model. J. exp. Med., 59, 173-180 (1989).